Lingotto Investment Management’s Paramount Global Class B PARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-51,040,940
Closed -$658M 44
2025
Q2
$658M Buy
51,040,940
+5,207,778
+11% +$61M 14% 2
2025
Q1
$548M Buy
45,833,162
+1,079,863
+2% +$12.1M 14.32% 2
2024
Q4
$468M Buy
44,753,299
+1,593,579
+4% +$17.1M 12.56% 3
2024
Q3
$458M Buy
43,159,720
+13,222,713
+44% +$144M 13.22% 3
2024
Q2
$311M Buy
29,937,007
+25,829,185
+629% +$303M 10.45% 3
2024
Q1
$48.3M Buy
4,107,822
+843,844
+26% +$10.6M 2.02% 12
2023
Q4
$48.4M Buy
3,263,978
+2,577,978
+376% +$34.5M 2.33% 11
2023
Q3
$8.85M Hold
686,000
0.47% 22
2023
Q2
$10.9M Hold
686,000
0.71% 21
2023
Q1
$15.4M Hold
686,000
1.1% 13
2022
Q4
$159M Hold
686,000
11.92% 2
2022
Q3
$13.2M Hold
686,000
1.21% 12
2022
Q2
$17M Buy
+686,000
New +$20.9M 1.65% 12
2022
Q1
Sell
-686,000
Closed -$159M 18
2021
Q4
$159M Buy
+686,000
New +$23.6M 11.92% 2

Other funds holding PARA

Lingotto Investment Management's PARA Position: Q3 2025 in Review

Lingotto Investment Management sold out of Paramount Global Class B (PARA) in Q3 2025, closing a stake of 51,040,940 shares — an estimated $658M sold.

Lingotto Investment Management first reported a position in PARA in Q4 2021 and held it in 14 quarters. The position peaked at $658M in Q2 2025. 8 funds tracked by Wall St. Rank hold PARA as of Q3 2025.

  • Lingotto Investment Management reported no remaining Paramount Global Class B position as of Q3 2025 after selling out during the quarter.
  • Lingotto Investment Management sold 51,040,940 Paramount Global Class B shares in Q3 2025, an estimated $658M.
  • Lingotto Investment Management first reported a position in Paramount Global Class B in Q4 2021 and held it in 14 quarters.
  • Lingotto Investment Management's Paramount Global Class B position peaked at $658M in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Paramount Global Class B as of Q3 2025.

Based on Lingotto Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.